LPAR—substituted cyanopyrazole compounds
US9169215B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2013 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Sep 2, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the formula (I), as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such pulmonary fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.